Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.39B |
| 2 |
ANDV
Andeavor
ANDV
|
+$1B |
| 3 |
Citigroup
C
|
+$332M |
| 4 |
Apple
AAPL
|
+$307M |
| 5 |
Oracle
ORCL
|
+$228M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AABA
Altaba Inc
AABA
|
+$579M |
| 2 |
EA
Electronic Arts
EA
|
+$233M |
| 3 |
Keurig Dr Pepper
KDP
|
+$215M |
| 4 |
APC
Anadarko Petroleum
APC
|
+$206M |
| 5 |
XL
XL Group Ltd.
XL
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.09% |
| 2 | Financials | 12.89% |
| 3 | Healthcare | 12.4% |
| 4 | Consumer Discretionary | 9.65% |
| 5 | Industrials | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Wynn Resorts
WYNN
$10.2B
| $17.3M | 0.02% |
135,868
-57,275
| -30% | -$8.5M |
|
|
AMWD
927
DELISTED
American Woodmark
AMWD
| $17.2M | 0.02% |
219,089
+40,166
| +22% | +$3.43M |
|
928
CALL
iShares Biotechnology ETF
IBB
$10.7B
| $17.1M | 0.02% |
140,600
-18,600
| -12% | -$2.19M |
|
929
Albany International
AIN
$1.66B
| $17.1M | 0.02% |
+215,553
| New | +$15.6M |
|
930
John Wiley & Sons Class A
WLY
$2.7B
| $17M | 0.02% |
280,816
-14,406
| -5% | -$896K |
|
931
New York Times
NYT
$10.9B
| $17M | 0.02% |
734,930
+434,670
| +145% | +$10.4M |
|
|
NXH
932
Neighborhood Intelligence Inc
NXH
$372M
| $16.9M | 0.02% |
814,014
+188,119
| +30% | +$4.64M |
|
933
Columbia Sportswear
COLM
$3.08B
| $16.8M | 0.02% |
180,735
-212,571
| -54% | -$19.3M |
|
|
MTOR
934
DELISTED
MERITOR, Inc.
MTOR
| $16.8M | 0.02% |
868,025
+18,946
| +2% | +$398K |
|
935
United Therapeutics
UTHR
$22B
| $16.8M | 0.02% |
131,252
+84,262
| +179% | +$10.4M |
|
936
Bio-Techne
TECH
$11.3B
| $16.8M | 0.02% |
+328,376
| New | +$14.5M |
|
|
AMED
937
DELISTED
Amedisys
AMED
| $16.7M | 0.02% |
133,879
-34,296
| -20% | -$3.79M |
|
938
CALL
Moody's
MCO
$88.6B
| $16.7M | 0.02% |
+100,000
| New | +$17.6M |
|
939
Teva Pharmaceuticals
TEVA
$43B
| $16.7M | 0.02% |
774,261
-4,851,590
| -86% | -$113M |
|
940
Simpson Manufacturing
SSD
$7.69B
| $16.7M | 0.02% |
229,886
+213,799
| +1,329% | +$15.2M |
|
|
GMS
941
DELISTED
GMS Inc
GMS
| $16.7M | 0.02% |
717,788
-428,066
| -37% | -$10.9M |
|
942
PUT
Texas Instruments
TXN
$236B
| $16.6M | 0.02% |
155,100
+141,600
| +1,049% | +$15.7M |
|
|
SAVE
943
DELISTED
Spirit Airlines, Inc.
SAVE
| $16.6M | 0.02% |
354,085
-529,935
| -60% | -$23.4M |
|
|
RDS.B
944
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $16.6M | 0.02% |
234,448
-66,556
| -22% | -$4.61M |
|
945
Seagate
STX
$180B
| $16.6M | 0.02% |
350,711
-394,439
| -53% | -$21.1M |
|
946
Lattice Semiconductor
LSCC
$16.2B
| $16.6M | 0.02% |
2,075,519
+1,904,872
| +1,116% | +$14.1M |
|
947
Mercury Insurance
MCY
$5.89B
| $16.6M | 0.02% |
330,316
+286,680
| +657% | +$14.3M |
|
948
Royal Gold
RGLD
$22.3B
| $16.5M | 0.02% |
214,523
+192,357
| +868% | +$15.8M |
|
949
Ternium
TX
$10.8B
| $16.4M | 0.02% |
543,012
-37,333
| -6% | -$1.18M |
|
|
CLR
950
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $16.4M | 0.02% |
240,862
-1,174,713
| -83% | -$74.2M |
|
Similar funds
Israel Englander's Q3 2018 Portfolio in Review
As of Q3 2018, Israel Englander held 4,590 positions worth $81.6B, up 6.4% from $76.7B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Israel Englander's Q3 2018 filing shows 841 new, 1,291 increased, 1,638 reduced and 748 closed positions. Its largest new stake was Fortive: 27,116,929 shares worth $1.44B. The largest sale was Altaba Inc, an estimated $579M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
- Israel Englander's largest Q3 2018 buy was Fortive: 27,116,929 shares worth $1.44B.
- Israel Englander added most to Andeavor in Q3 2018, an estimated $1B increase.
- Israel Englander's biggest Q3 2018 reduction was Altaba Inc, cutting an estimated $579M.
- Israel Englander fully exited XL Group Ltd. in Q3 2018, selling an estimated $190M.
- Israel Englander's ten largest holdings make up 10% of its $81.6B portfolio in Q3 2018.
- Israel Englander opened 841 new positions and closed 748 in Q3 2018.
- Israel Englander's portfolio value rose 6.4% quarter-over-quarter to $81.6B.
Based on Millennium Management's 13F filing for Q3 2018, filed 14 Nov 2018.